Drugs / Norbuprenorphine
last change Jun 2016 re-read 9 days ago

Norbuprenorphine

Small molecule

Investigated by
GlaxoSmithKline · ViiV Healthcare

Trials 1

201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02666001 Jan → Jun 2016 HIV infectious disease ViiV Healthcare Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Norbuprenorphine ClinicalTrials.gov intervention name — accepted as the source's own label NCT02666001 ↗
Modality Small molecule — CHEMBL1743323 ↗